Conference Proceedings

Bortezomib and dexamethasone from cycle 1 as treatment and maintenance for multiple myeloma relapse (The BoMeR trial): Impact on response and time to progression

SJ Harrison, H Quach, J Dean, A Milner, MC Copeman, HM Prince

Journal of Clinical Oncology | AMER SOC CLINICAL ONCOLOGY | Published : 2010